Previous close | 204.00 |
Open | 202.82 |
Bid | 203.09 x 900 |
Ask | 203.20 x 1800 |
Day's range | 202.07 - 205.40 |
52-week range | 186.67 - 252.67 |
Volume | |
Avg. volume | 8,137,998 |
Market cap | 436.425B |
Beta (5Y monthly) | 0.92 |
PE ratio (TTM) | 31.90 |
EPS (TTM) | 6.36 |
Earnings date | 25 Jul 2022 - 29 Jul 2022 |
Forward dividend & yield | 1.50 (0.76%) |
Ex-dividend date | 12 May 2022 |
1y target est | 269.26 |
Mastercard (MA) launches the Biometric Checkout Program, which empowers consumers to make biometric payments without mobile wallets or cards to ensure accelerated checkout experiences.
These household brands are used by millions of people every day, and their stocks offer a growth opportunity for long-term investors.
Is American Express (NYSE: AXP) worth buying at its current valuation? In this clip from "The Rank" on Motley Fool Live, recorded on April 25, Motley Fool contributors Matt Frankel, Jason Hall, and Zane Fracek discuss where they ranked American Express and whether it's a good buy given its current valuation. Matt Frankel: This is Berkshire's (NYSE: BRK.A) (NYSE: BRK.B) third largest holding now.